News and Events

Gore Recognizes Physicians as "Pioneers in Performance" for Exceptional Work in the Field of Vascular Surgery and Endovascular Therapy


Leading Practitioners and Researchers from Around the World Commended for Expanding Treatment Options for At-Risk Patients

Flagstaff, AZ (April 12, 2010)—W. L. Gore & Associates (Gore) announced it has honored eight physicians from around the world as "Pioneers in Performance" for their exceptional work in the field of vascular and endovascular therapy, including aortic and lower-limb bypass and dialysis access surgery. These practitioners were recognized by Gore for their unrelenting dedication to advancing vascular and endovascular therapy and the advancement of minimally invasive treatment options for patients worldwide. The work performed by these individuals has expanded therapeutic options for at-risk patients.

A celebration was held in honor of the "Pioneers in Performance" during the 32nd International Symposium Charing Cross – Controversies, Challenges, Consensus held in London, UK, April 10-13, 2010. The physicians recognized by Gore included:

  • Dr. Gary Ansel, Cardiologist, Internist, Clinical Director of Peripheral Vascular Intervention, Riverside Methodist Hospital, Columbus, Ohio, USA
  • Prof. Jan Brunkwall, Professor, University of Cologne, Chief of the Department of Vascular Surgery, University Clinics Cologne, Germany
  • Mr. Eric Chemla, Consultant Renal Transplant and Vascular Surgeon, Chair of the Division of Medicine and Cardiovascular Sciences, St George's Hospital, London, UK 
  • Prof. Roger Greenhalgh, Emeritus Professor of Surgery and Head of the Imperial College of Vascular Surgical Research Group, London, UK and Medical Director of BIBA Medical, Ltd. (organizes the Charing Cross International Symposium)
  • Dr. Thomas Larzon, Consultant Vascular Surgeon, Örebro University Hospital, Örebro, Sweden
  • Mr. Peter Taylor, Mchir FRCS, Consultant Vascular Surgeon, Guy's & St Thomas' Hospital, London, UK
  • Prof. Jan Tordoir, Associate Professor of Surgery at the Department of Surgery, Head of the Noninvasive Vascular Lab, University Hospital Maastricht, The Netherlands
  • Dr. EricVerhoeven, Specialist in Surgery and Vascular Surgery, Medical Director of the Department of Vascular Surgery, Nuremberg Hospital South, Nuremberg, Germany

"We are proud to recognize these 'Pioneers' for their extraordinary contributions to the vascular community," said Marty Sylvain, global sales leader at Gore. "Gore prides itself on continually pursuing new, innovative technologies that improve patients' lives. The work and dedication of these researchers and clinicians are critical in helping us develop products that embody innovation, reliability and proven performance."

The collaboration between Gore and physician pioneers has resulted in the development of minimally invasive treatment options for safely and effectively managing patients with aneurysms including the Conformable GORE® TAG® Thoracic Endoprosthesis and the GORE® EXCLUDER® AAA Endoprosthesis. These important partnerships have also yielded first-in-class products such as the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface, which is used to treat patients with peripheral vascular disease (PVD), and the GORE® PROPATEN® Vascular Graft for peripheral use, including lower-limb bypass and dialysis access surgery.

About W. L. Gore & Associates

The Gore Medical Products Division has provided creative therapeutic solutions to complex medical problems for over three decades. During that time, more than 25 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. The extensive Gore Medical family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia repair, soft tissue reconstruction, staple line reinforcement, and sutures for use in vascular, cardiac and general surgery. Gore was recently named one of the best companies to work for by Fortune magazine for the 13th consecutive year. For more information, visit goremedical.com.

About 32nd International Symposium Charing Cross

In its 32nd year, the International Symposium Charing Cross – Controversies, Challenges, Consensus, held in London, is an educational forum which takes place over four days. The plenary sessions run in a logical sequence starting with carotids and the lower limb on Saturday, the abdominal aorta on Sunday, the thoracic aorta and more carotids on Monday, renals and venous on Tuesday. Once again, a world class faculty discusses controversial topics, challenges the evidence, and takes part in a series of head-to-head debates to reach a consensus after discussion. cxsymposium.com.

Contacts

Nicki Polatin or Shannon Murphy
Schwartz Communications, Inc. for W. L. Gore & Associates
781-684-0770 or 415-512-0770
GoreMedical@schwartz-pr.com

Products listed may not be available in all markets. GORE®, EXCLUDER®, PROPATEN®, TAG®, VIABAHN®, and designs are trademarks of W. L. Gore & Associates.